P40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma

Journal of Cutaneous Pathology

Volumn 41, Issue 11, 2014, Pages 839-845

  Alomari, Ahmed K ^a   Glusac, Earl J ^a   McNiff, Jennifer M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cutaneous squamous cell carcinoma; immunocytochemistry; immunohistochemistry; p63; squamous cell carcinomas

Indexed keywords

ISOPROTEIN; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TISSUE MICROARRAY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEIN ISOFORMS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84913537598     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12388     Document Type: Article

References (33)

1. Weedon D,. Tumors of the epidermis. In Weedon's skin pathology, 3rd ed. London: Churchill Livingstone Elsevier, 2010; 691.
2. Ko CJ, McNiff JM, Glusac EJ,. Squamous cell carcinomas with single cell infiltration: a potential diagnostic pitfall and the utility of MNF116 and p63. J Cutan Pathol 2008; 35: 353.
3. Prieto VG1, Lugo J, McNutt NS,. Intermediate- and low-molecular-weight keratin detection with the monoclonal antibody MNF116. Animmunohistochemical study on 232 paraffin-embedded cutaneous lesions. J Cutan Pathol 1996; 23: 234.
4. Sigel JE, Skacel M, Bergfeld WF, House NS, Rabkin MS, Goldblum JR,. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2001; 28: 520.
5. Buonaccorsi JN, Plaza JA,. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases. Am J Dermatopathol 2012; 34: 404.
6. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305.
7. Ocque R, Tochigi N, Ohori NP, Dacic S,. Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens. Am J Clin Pathol 2011; 136: 81.
8. Bishop JA, Montgomery EA, Westra WH,. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol 2014; 38: 257.
9. Dotto JE, Glusac EJ,. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2006; 33: 413.
10. Hall JM, Saenger JS, Fadare O,. Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas. Int J Clin Exp Pathol 2008; 1: 524.
11. Qureshi HS, Ormsby AH, Lee MW, Zarbo RJ, Ma CK,. The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol 2004; 31: 145.
12. Ivan D, Hafeez Diwan A, Prieto VG,. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol 2005; 18: 137.
13. Geddert H, Kiel S, Heep HJ, Gabbert HE, Sarbia M,. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol 2003; 34: 850.
14. de Feraudy S, Mar N, McCalmont TH,. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol 2008; 32: 1111.
15. Luzar B, Calonje E,. Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review. J Cutan Pathol 2010; 37: 301.
16. Kavalar R, Pohar Marinsek Z, Jereb B, Cagran B, Golouh R,. Prognostic value of immunohistochemistry in the Ewing's sarcoma family of tumors. Med Sci Monit 2009; 15: CR442.
17. Sebire NJ, Gibson S, Rampling D, Williams S, Malone M, Ramsay AD,. Immunohistochemical findings in embryonal small round cell tumors with molecular diagnostic confirmation. Appl Immunohistochem Mol Morphol 2005; 13: 1.
18. Mooi WJ, Deenik W, Peterse JL, Hogendoorn PC,. Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma). Histopathology 1995; 27: 61.
19. Pauli J, Gundelach R, Vanelli-Rees A, et al. Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell. Pathology 2008; 40: 396.
20. Chia Y, Thike AA, Cheok PY, Yong-Zheng Chong L, Man-Kit Tse G, Tan PH,. Stromal keratin expression in phyllodes tumours of the breast: comparison with other spindle cell breast lesions. J Clin Pathol 2012; 65: 339.
21. Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA,. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope 2004; 114: 2063.
22. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gärtner F, Schmitt FC,. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 2003; 443: 122.
23. Nobre AR, Albergaria A, Schmitt F,. p40: a p63 isoform useful for lung cancer diagnosis-a review of the physiological and pathological role of p63. Acta Cytol 2013; 57: 1.
24. Kim MJ, Shin HC, Shin KC, Ro JY,. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Ann Diagn Pathol 2013; 17: 85.
25. Lewis JS, Ritter JH, El-Mofty S,. Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1. Mod Pathol 2005; 18: 1471.
26. Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N,. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 2012; 25: 405.
27. Lee JJ, Mochel MC, Piris A, Boussahmain C, Mahalingam M, Hoang MP,. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases. Hum Pathol 2014; 45: 1078.
28. Henderson SA, Torres-Cabala CA, Curry JL, et al. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies. Am J Surg Pathol 2014; 38: 1102.
29. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC,. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 2002; 29: 517.
30. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002; 8: 494.
31. Jo VY, Fletcher CD,. p63 immunohistochemical staining is limited in soft tissue tumors. Am J Clin Pathol 2011; 136: 762.
32. Tilson MP, Bishop JA,. Utility of p40 in the differential diagnosis of small round blue cell tumors of the sinonasal tract. Head Neck Pathol 2014; 8: 141.
33. Martin SE, Temm CJ, Goheen MP, Ulbright TM, Hattab EM,. Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study. Mod Pathol 2011; 24: 1320.